Research Study
View Full Study →
Astragaloside IV supplementation attenuates cognitive impairment by inhibiting neuroinflammation and oxidative stress in type 2 diabetic mice.
Citation
Zhang Y., Yuan Y., Zhang J., Zhao Y., Zhang Y. et al. (2022). Astragaloside IV supplementation attenuates cognitive impairment by inhibiting neuroinflammation and oxidative stress in type 2 diabetic mice.. Front Aging Neurosci. DOI: 10.3389/fnagi.2022.1004557
Abstract
Abstract not available. See citation for source.
Disclaimer: This research summary is for educational purposes only. Always consult with a healthcare professional before making decisions based on scientific research.